ARTIFICIAL INTELLIGENCE AND INTEGRATIVE COMPUTATIONAL STRATEGIES FOR TARGETING RNA-BINDING PROTEINS IN PRECISION ONCOLOGY: OVERCOMING THE UNARGUABILITY PARADIGM
Scientific Records · 04.08.2026 · 127
DOI: 10.62324/journal.sr/2026.073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Records, online erschienen am 04.08.2026.
Abstract (Originalsprache)
RNA-binding proteins (RBPs) have emerged as critical regulators of cancer progression, yet their therapeutic targeting has been historically constrained by the so-called pharmacological intractability paradigm.Conventional reviews have extensively catalogued small-molecule inhibitors, antisense oligonucleotides, and aptamers against established RBP targets such as eIF4F, FTO, SF3B1, RBM39, and the nucleolar phosphoprotein.However, a significant knowledge gap persists regarding the integration of artificial intelligence (AI), structural genomics, and multi-omics data to systematically overcome the structural and functional complexities that render RBPs refractory to traditional drug discovery.This review addresses this gap by examining how AlphaFold3-enabled structural biology, deep learning-based RBP-RNA interaction prediction, CRISPR functional genomics, and computational drug design are transforming the RBP therapeutic landscape.We discuss the application of machine learning to predict cryptic binding pockets within intrinsically disordered regions, the use of genome-wide dropout screens to map context-specific RBP dependencies, and the emergence of PROTAC and molecular glue degraders optimized through structure-based design.Furthermore, we explore how single-cell multi-omics and integrative biomarker models enable patient stratification for RBP-targeted therapies.By synthesizing these computational advances, we propose a framework for precision oncology in which AI-driven target identification, rational drug design, and predictive biomarker discovery converge to unlock the therapeutic potential of the RB-Pome.
Zitieren
APA
(2026). ARTIFICIAL INTELLIGENCE AND INTEGRATIVE COMPUTATIONAL STRATEGIES FOR TARGETING RNA-BINDING PROTEINS IN PRECISION ONCOLOGY: OVERCOMING THE UNARGUABILITY PARADIGM. Scientific Records, 127. https://doi.org/10.62324/journal.sr/2026.073
Vancouver
ARTIFICIAL INTELLIGENCE AND INTEGRATIVE COMPUTATIONAL STRATEGIES FOR TARGETING RNA-BINDING PROTEINS IN PRECISION ONCOLOGY: OVERCOMING THE UNARGUABILITY PARADIGM. Scientific Records. 2026:127. doi:10.62324/journal.sr/2026.073
BibTeX
@article{euvimed2026,
title = {ARTIFICIAL INTELLIGENCE AND INTEGRATIVE COMPUTATIONAL STRATEGIES FOR TARGETING RNA-BINDING PROTEINS IN PRECISION ONCOLOGY: OVERCOMING THE UNARGUABILITY PARADIGM},
journal = {Scientific Records},
year = {2026},
pages = {127},
doi = {10.62324/journal.sr/2026.073}
}
EUVIMED